The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice

被引:29
|
作者
Burns, Ted M. [1 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源
关键词
MG composite; myasthenia gravis; outcome measures; MGC; MG; MYCOPHENOLATE-MOFETIL; RECOMMENDATIONS; CYCLOSPORINE; RELIABILITY; VALIDATION; STANDARDS; IVIG;
D O I
10.1111/j.1749-6632.2012.06812.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The myasthenia gravis composite (MGC) was constructed by selecting the best performing items from three commonly used, MG-specific scales. The response categories of the items were subsequently weighted for importance. The MGC, which takes less than five minutes to complete, is made up of three ocular, three bulbar, one respiratory, one neck, and two limb items. After its construction, the MGC was validated in an 11-center scale validity study. During the validation study, which included test-retest analysis, it was determined that a 3-point improvement in MGC score reliably indicates clinical improvement. A 3-point improvement in MGC also appears to be meaningful to the patient. Rasch analysis of the MGC confirmed that all 10 items belong and can be summed to provide a total score, and that the weights given to the response categories of the items are appropriate.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [1] The MG Composite A valid and reliable outcome measure for myasthenia gravis
    Burns, Ted M.
    Conaway, Mark
    Sanders, Donald B.
    NEUROLOGY, 2010, 74 (18) : 1434 - 1440
  • [2] ADDRESSING OUTCOME MEASURE VARIABILITY IN MYASTHENIA GRAVIS CLINICAL TRIALS
    Guptill, Jeffrey T.
    Granit, Volkan
    Habib, Ali
    Lee, Ikjae
    Ruzhansky, Katherine
    Howard, James F., Jr.
    Barnett-Tapia, Carolina
    Dimachkie, Mazen M.
    Nowak, Richard J.
    Kaminski, Henry J.
    Benatar, Michael
    MUSCLE & NERVE, 2022, 65 : S11 - S12
  • [3] Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
    Guptill, Jeffrey T.
    Benatar, Michael
    Granit, Volkan
    Habib, Ali A.
    Howard, James F.
    Barnett-Tapia, Carolina
    Nowak, Richard J.
    Lee, Ikjae
    Ruzhansky, Katherine
    Dimachkie, Mazen M.
    Cutter, Gary R.
    Kaminski, Henry J.
    NEUROLOGY, 2023, 101 (10) : 442 - 451
  • [4] Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis
    Thomsen, Jan Lykke Scheel
    Andersen, Henning
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [5] Clinical trials in myasthenia gravis
    Mahmood, A.
    Hawken, J.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4579 - 4581
  • [6] Clinical trials in myasthenia gravis
    A. Mahmood
    J. Hawken
    N. P. Robertson
    Journal of Neurology, 2023, 270 : 4579 - 4581
  • [7] Myasthenia gravis in clinical practice
    Estephan, Eduardo de Paula
    Soares Baima, Jose Pedro
    Zambon, Antonio Alberto
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (05) : 257 - 265
  • [8] Recommendations for myasthenia gravis clinical trials
    Li, Hai-feng
    Gao, Xiang
    Xie, Yan-chen
    MUSCLE & NERVE, 2013, 47 (01) : 144 - 145
  • [9] Recommendations for myasthenia gravis clinical trials
    Benatar, Michael
    Sanders, Donald B.
    Burns, Ted M.
    Cutter, Gary R.
    Guptill, Jeffrey T.
    Baggi, Fulvio
    Kaminski, Henry J.
    Mantegazza, Renato
    Meriggioli, Matthew N.
    Quan, Joanne
    Wolfe, Gil I.
    MUSCLE & NERVE, 2012, 45 (06) : 909 - 917
  • [10] Clinical trials for myasthenia gravis: a historical perspective
    Kaminski, Henry J.
    Alnosair, Eman
    Algahtani, Rami M.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1413 (01) : 5 - 10